novartis glp-1 receptor agonist Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine GLP1 Receptor Agonists—Effects beyond Obesity

People using GLP-1 medication at their standard dose may experience the full therapeutic effect, in contrast to others who are microdosing

Studies and clinical trials show that when people stop taking GLP-1s, the appetite often comes back, and in many cases there is rapid weight regain, especially if nutrition and behavior changes werent made when on the medication, she says

Klausen MK, Thomsen M, Wortwein G, et al

In an additional scenario, reduced ERK1/2 and MAPK activity hindered muscle glucose transport and caused insulin resistance (IR) [42]

On the basis of these findings, a clinical study program was started to investigate the efficacy and safety of tirzepatide in the treatment of obesity and obesity management